Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.-论文-万方医学网

第一作者： Stefan O,Ciurea

第一单位： Department of Stem Cell Transplantation and Cellular Therapy.

作者： Stefan O,Ciurea ^[1] ; Jolie R,Schafer ^[2] ; Roland,Bassett ^[3] ; Cecele J,Denman ^[4] ; Kai,Cao ^[5] ; Dana,Willis ^[5] ; Gabriela,Rondon ^[1] ; Julianne,Chen ^[1] ; Doris,Soebbing ^[1] ; Indreshpal,Kaur ^[6] ; Alison,Gulbis ^[7] ; Sairah,Ahmed ^[1] ; Katayoun,Rezvani ^[1] ; Elizabeth J,Shpall ^[1] ; Dean A,Lee ^[8] ; Richard E,Champlin ^[1]

作者单位： Department of Stem Cell Transplantation and Cellular Therapy. ^[1] Department of Pediatrics. ^[2] Department of Biostatistics. ^[3] Department of Immunology. ^[4] Department of Laboratory Medicine. ^[5] Good Manufacturing Practice Laboratory, and. ^[6] Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX; and. ^[7] Division of Hematology, Oncology, and Bone Marrow Transplantation, Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH. ^[8]

医学主题词青少年(Adolescent);成年人(Adult);老年人(Aged);血液成分输血(Blood Component Transfusion);细胞培养技术(Cell Culture Techniques);细胞增殖(Cell Proliferation);细胞, 培养的(Cells, Cultured);女(雌)性(Female);单倍型(Haplotypes);血液肿瘤(Hematologic Neoplasms);组织相容性试验(Histocompatibility Testing);人类(Humans);白细胞介素类(Interleukins);K562细胞(K562 Cells);杀伤细胞, 天然(Killer Cells, Natural);男(雄)性(Male);膜蛋白质类(Membrane Proteins);中年人(Middle Aged);组织供者(Tissue Donors);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1182/blood-2017-05-785659

PMID 28835441

发布时间 2025-01-03

检索历史清除

Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.

Blood

相似文献

同项目论文

Blood

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.

Blood

相似文献

同项目论文

Blood

相关期刊

检索历史清除